The European Molecular Biology Organization (EMBO) today announces the election of 49 top researchers to its membership. Election as an EMBO Member is a tribute to the key research being carried out by these scientists, who join the ranks of Europe´s foremost life sciences community.
Seattle, Wednesday, October 11, 2006 – The Institute for Systems Biology (ISB), an internationally renowned non-profit research institute in Seattle dedicated to the study and application of systems biology, announced a new breakthrough in the study of risk factors associated with Type 1 Diabetes. Researchers have identified a gene, ITPR3, associated with the disease. ITPR3 regulates calcium flow within cells. An article about this study will appear in the October issue of the American Journal of Human Genetics.
BOTHELL, WA. (October 04, 2006) -- Lumera Corporation (NASDAQ: LMRA), the world's leading provider of light applied nanotechnology, announced an expanded collaboration agreement with the Institute for Systems Biology (ISB), an internationally renowned non-profit research institute dedicated to the study and application of systems biology. The revised collaboration agreement will focus on detection methods for an array of diagnostic biomarkers aimed at a various types of cancer.
PITTSBURGH--September 25, 2006--The owner of 14 breakthrough patents in the biomedical arena, including the DNA gene sequencer that laid the foundation for the Human Genome Project, has been selected to receive the 12th Annual Heinz Award for Technology, the Economy and Employment, one of the largest individual achievement prizes in the world.
"I think the thing that is most unique about P4 Medicine is that it will represent a network of networks - genetic networks, molecular networks, cellular networks, tissue networks, individual networks, population networks, social networks."
President of Institute for Systems Biology
Director of Communications